| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3843969 | Actas Urológicas Españolas | 2010 | 9 Pages |
Abstract
The current available evidence is not enough to support a presumed «drug class effect» among the various analogues in the treatment of prostate carcinoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
S. Vilar-González, X. Maldonado-Pijuan, I. Andrés-GarcÃa,